Sign In
Buy PURE
$0.0640
-0.0010 (-1.54%)
At Close: Jul 31, 2026
MACOM Introduces New GaN-on-Silicon Carbide (SiC) Power Amplifier Product Line MACOM PURE CARBIDETM
12:00am, Thursday, 06'th Aug 2020
MACOM Technology Solutions Inc. (“MACOM”), a leading supplier of semiconductor solutions, today announced at the virtual International Microwave Sympo
PURE Bioscience Sets Fiscal 2019 Third Quarter and Nine-Month Financial Results Call
08:36am, Wednesday, 22'nd May 2019
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 13, 2019 the Company wil
PURE Bioscience Sets Fiscal 2019 Second Quarter and Six-Month Financial Results Call
08:36am, Wednesday, 13'th Feb 2019
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on March 6, 2019 the Company wil
PURE Bioscience Sets Fiscal 2019 Q1 Financial Results Conference Call
04:06pm, Thursday, 29'th Nov 2018
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 13, 2018 the Company
PURE Bioscience Sets Conference Call to Report 2018 Fiscal Year-End Financial Results
08:36am, Monday, 08'th Oct 2018
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on October 25, 2018 the Company
PURE Bioscience Sets Conference Call to Report 2018 Fiscal Third Quarter and Nine-Month Financial Results
08:36am, Wednesday, 30'th May 2018
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 13, 2018 the Company wil
PURE Bioscience Sets Fiscal 2018 Q2 Financial Results Conference Call
08:36am, Thursday, 01'st Mar 2018
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on March 14, 2018 the Company wi
PURE Bioscience Sets Fiscal 2018 Q1 Financial Results Conference Call
08:36am, Tuesday, 28'th Nov 2017
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 14, 2017 the Company
PURE Bioscience to Host Fiscal 2017 Year-End Financial Results Conference Call
08:36am, Monday, 02'nd Oct 2017
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented, non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that on October 26, 2017 the Company
PURE Bioscience to Present at 2017 SeeThru Equity Investor Conference
08:36am, Thursday, 14'th Sep 2017
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company will present at the 2
PURE Bioscience Sets Q3 Results Conference Call to Review Progress of SDC-Based Antimicrobial Food Safety Solutions Strategy
08:36am, Tuesday, 30'th May 2017
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will publish fiscal Q
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, announced today that the Company will publish fiscal Q
PURE Bioscience Sets Fiscal 2017 Q1 Results Conference Call
08:36am, Wednesday, 30'th Nov 2016
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on December 14, 2016 the Company will file
PURE Bioscience to Host Fiscal 2016 Year-End Financial Results Conference Call
08:36am, Thursday, 13'th Oct 2016
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on October 27, 2016 the Company will file i
SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience, Inc. (OTCQB: PURE), creator of the patented silver dihydrogen citrate (SDC) antimicrobial, announced today that on June 9, 2016 the Company will file its F
